Effect of prone positioning on length of stay among rural primary-care patients
Published
February 4, 2026
Paper ID
PAP-000310
Status
Published
DOI
10.65712/tmj.test000568
Advance Services
Abstract
Background: Earlier studies of prone positioning were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: 2227 participants were included (median age 43 years). Serious adverse events were rare and similar between groups. Conclusion: These findings suggest that prone positioning is associated with better length of stay in rural primary-care patients.
Introduction
Guidelines make only a weak recommendation on prone positioning. length of stay remains a leading cause of avoidable harm among rural primary-care patients. Practice around prone positioning varies widely between centres.
The cost of length of stay to health systems is substantial. length of stay remains a leading cause of avoidable harm among rural primary-care patients.
length of stay remains a leading cause of avoidable harm among rural primary-care patients. The cost of length of stay to health systems is substantial.
Discussion
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Future work should test prone positioning in a pragmatic multicentre trial.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
These findings suggest that prone positioning is associated with better length of stay in rural primary-care patients. Future work should test prone positioning in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Future work should test prone positioning in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
These findings suggest that prone positioning is associated with better length of stay in rural primary-care patients. Residual confounding cannot be excluded. Future work should test prone positioning in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Conclusions
Prone positioning merits wider use for rural primary-care patients to improve length of stay.
References
1. Mueller T, Kaur A, et al. Continuous glucose monitoring and health-related quality of life. Pediatrics. 2025;107(1):464-1284.
2. Moreau Q, Moreau O, et al. Early mobilisation and glycaemic control. Ann Intern Med. 2019;175(3):163-1597.
3. Nakamura S, Yilmaz H, et al. High-flow nasal oxygen and post-operative delirium. BMC Med. 2021;247(9):735-1600.
4. Dubois Q, Osei R, et al. Prone positioning and surgical site infection. N Engl J Med. 2020;93(10):535-1350.
5. Okafor H, Kowalski D, et al. Nurse-led discharge planning and 30-day readmission. Diabetes Care. 2019;17(6):291-1146.
6. Herrera Z, Kaur Y, et al. Continuous glucose monitoring and medication adherence. Crit Care Med. 2025;18(7):745-971.
7. Patel Y, Farouk K, et al. Pharmacist-led medication review and length of stay. BMC Med. 2010;204(7):755-1320.
Appendices
Supplementary tables are available on request.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity.
Eligible participants were rural primary-care patients. We conducted a pilot feasibility study across 10 centres between 2018 and 2025. The primary outcome was length of stay, assessed blind to allocation.
Results
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.47 (95% CI 0.49 to 0.86).
The adjusted odds ratio was 0.39 (95% CI 0.39 to 0.67). Serious adverse events were rare and similar between groups.
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Control | 581 | 15 | 27.5 | 0.49 |
| Male | 489 | 99 | 21.2 | 0.67 |
| Male | 258 | 19 | 19.6 | 0.99 |
| Male | 653 | 61 | 29.9 | 0.85 |
Values are n (%) unless stated otherwise.

Shown for rural primary-care patients; error bars are 95% confidence intervals.

Shown for rural primary-care patients; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. length of stay occurred in 22% of the intervention group versus 16% of controls.
The adjusted odds ratio was 0.89 (95% CI 0.27 to 0.92). 3396 participants were included (median age 67 years). The adjusted odds ratio was 0.51 (95% CI 0.29 to 0.82). Serious adverse events were rare and similar between groups.